JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugimoto, Y.
Right arrow Articles by Kurose, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugimoto, Y.
Right arrow Articles by Kurose, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Vol. 301, Issue 1, 51-58, April 2002

beta 1-Selective Agonist (-)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(-)-RO363] Differentially Interacts with Key Amino Acids Responsible for beta 1-Selective Binding in Resting and Active States

Yoshiyuki Sugimoto1 , Reiko Fujisawa, Ryuji Tanimura, Anne Laure Lattion, Susanna Cotecchia, Gozoh Tsujimoto, Taku Nagao and Hitoshi Kurose

Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan (Y.S., R.F., T.N., H.K.); Toray Industries, Inc., Basic Research Laboratories, Kanagawa, Japan (R.T.); Department of Molecular, Cell Pharmacology, National Children's Medical Research Center, Tokyo, Japan (G.T.); and Institute de Pharmacologie et de Toxicologie, Lausanne, Switzerland (A.L.L., S.C.)

(-)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(-)-RO363] is a highly selective beta 1-adrenergic receptor (beta 1AR) agonist. To study the binding site of beta 1-selective agonist, chimeric beta 1/beta 2ARs and Ala-substituted beta 1ARs were constructed. Several key residues of beta 1AR [Leu110 and Thr117 in transmembrane domain (TMD) 2], and Phe359 in TMD 7] were found to be responsible for beta 1-selective binding of (-)-RO363, as determined by competitive binding. Based on these results, we built a three-dimensional model of the binding domain for (-)-RO363. The model indicated that TMD 2 and TMD 7 of beta 1AR form a binding pocket; the methoxyphenyl group of N-substituent of (-)-RO363 seems to locate within the cavity surrounded by Leu110, Thr117, and Phe359. The amino acids Leu110 and Phe359 interact with the phenyl ring of (-)-RO363, whereas Thr117 forms hydrogen bond with the methoxy group of (-)-RO363. To examine the interaction of these residues with beta 1AR in an active state, each of the amino acids was changed to Ala in a constitutively active (CA)-beta 1AR mutant. The degree of decrease in the affinity of CA-beta 1AR for (-)-RO363 was essentially the same as that of wild-type beta 1AR when mutated at Leu110 and Thr117. However, the affinity was decreased in Ala-substituted mutant of Phe359 compared with that of wild-type beta 1AR. These results indicated that Leu110 and Thr117 are necessary for the initial binding of (-)-RO363 with beta 1-selectivity, and interaction of Phe359 with the N-substituent of (-)-RO363 in an active state is stronger than in the resting state.


1 Present address: Kyowa-Hakko Co., Simotogari 1179, Nagaizumi, Suntoh-gun, Shizuoka 411-0943, Japan.


0022-3565/02/3011-0051$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
ScienceHome page
D. M. Rosenbaum, V. Cherezov, M. A. Hanson, S. G. F. Rasmussen, F. S. Thian, T. S. Kobilka, H.-J. Choi, X.-J. Yao, W. I. Weis, R. C. Stevens, et al.
GPCR Engineering Yields High-Resolution Structural Insights into 2-Adrenergic Receptor Function
Science, November 23, 2007; 318(5854): 1266 - 1273.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Yin, S. Gavi, H.-y. Wang, and C. C. Malbon
Probing Receptor Structure/Function with Chimeric G-Protein-Coupled Receptors
Mol. Pharmacol., June 1, 2004; 65(6): 1323 - 1332.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.